Radiolabeled Compounds in the Development of Cytotoxic Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2923-2934
Author(s):
Kalevi J.A. Kairemo and Marja Tahtinen
The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
511-520
Author(s):
Noriyuki Takai, Tami Ueda, Masakazu Nishida, Kaei Nasu and Isao Miyakawa
Antifolates - Past, Present and Future
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
405-410
Author(s):
Aleem Gangjee and Hiteshkumar D. Jain
Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
449-455
Author(s):
Tomi K. Sawyer
Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
403-424
Author(s):
M. C. Liu, J. L. Marshall and R. G. Pestell
Therapeutic Antibodies
Journal:
Current Molecular Medicine
Volume:
4
Page:
539-547
Author(s):
Bernd Groner, Cord Hartmann and Winfried Wels
Proteinase-Activated Receptor 2 (PAR2): A Challenging New Target for Treatment of Vascular Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2769-2778
Author(s):
John J. McGuire
DNA Methylation Leaves Its Mark in Head and Neck Squamous Cell Carcinomas (HNSCC)
Journal:
Current Genomics
Volume:
5
Page:
489-498
Author(s):
L. T. Smith and C. Plass
Lactate in Solid Malignant Tumors: Potential Basis of a Metabolic Classification in Clinical Oncology
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
2195-2204
Author(s):
S. Walenta, T. Schroeder and W. Mueller-Klieser
New Trends in the Development of Transcription Factor Decoy (TFD) Pharmacotherapy
Journal:
Current Drug Targets
Volume:
5
Page:
419-430
Author(s):
Roberto Gambari